Omico’s development and growth in precision oncology, recently boosted by significant funding in the 2026-27 Budget, is also producing a substantial library of patient-level data that demonstrates that genomic profiling of tumours changes lives and could reshape how Australia funds and delivers cancer care. …
Omico is evolving tumour genomics into hard evidence for precision oncology
June 8, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Queensland cardiac experts back a new plan to stop the second heart attack
September 18, 2026 - - Latest News -
We have one of Australia's answers to 'MFN' and people will die as a result
September 18, 2026 - - Latest News -
Is the fairest part of our medicines access system delivered overseas?
September 18, 2026 - - Latest News -
Mayne Pharma bets on an untapped corner of the menopause market
September 17, 2026 - - Latest News -
Genomic testing to reach more patients with hard to treat cancers
September 17, 2026 - - Latest News -
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
'Your success makes you a target and take it as a compliment'
September 16, 2026 - - Latest News